Chem. J. Chinese Universities ›› 2025, Vol. 46 ›› Issue (1): 20240267.doi: 10.7503/cjcu20240267

• Review • Previous Articles    

Research Progress of Precision Antitumor Medicine Based on Supramolecular Drug-delivery Nanosystems

CHEN Junnian, ZHANG Haifeng, WANG Haibing, YANG Huocheng, LUO Zhong()   

  1. School of Life Science,Chongqing University,Chongqing 400044,China
  • Received:2024-05-31 Online:2025-01-10 Published:2024-06-24
  • Contact: LUO Zhong E-mail:luozhong918@cqu.edu.cn
  • Supported by:
    the National Natural Science Foundation of China(92059107)

Abstract:

Cancer is a major threat to healthcare and people’s wellbeing worldwide. Despite the accumulative progress in current antitumor therapies including chemotherapy, radiotherapy, phototherapy and immunotherapy, cancer treatment still remains a major clinical challenge due to insufficient anticancer potency and serious side effects, which are largely associated with the uncontrollable drug release behavior. Therefore, targeted and controlled delivery of anticancer therapeutics to the tumor site emerges as a crucial task to improve tumor inhibition efficacy while alleviating adverse effects to normal cells and tissues. In recent years, drug-delivery nanosystems have gained much attention owing to its high drug loading capacity, low side effects, controllable drug release performance and good targeting effects. Among those emerging drug-delivery nanotechnologies based on supramolecular self-assembly are particularly attractive for cancer therapy on account of the unique dynamic and reversible interaction modes, which endow sensitivity to even small changes in the ambient environment. Based on the above knowledge, this review summarizes the latest progress of supramolecular delivery nanosystems, including the construction of different types of supramolecular nanostructures, controlled drug release strategies through harnessing supramolecular chemistries and biological applications of supramolecular drug delivery nanosystems. In addition, the prospect and key challenges of supramolecular drug delivery nanotechnology for precision cancer therapy are further discussed.

Key words: Drug delivery nanotechnology, Supramolecular self-assembly, Precision medicine, Controlled drug release, Tumor therapy

CLC Number: 

TrendMD: